Your browser doesn't support javascript.
loading
Reversible Cardiomyopathy, What Should the Clinicians Keep in Mind? A Case Report.
Alzahrani, Abdulmajeed A; Bahaidarah, Saud A; Al-Hassnan, Zuhair N; Abdelmohsen, Gaser A.
Afiliação
  • Alzahrani AA; Cardiac Surgery Division, Department of Surgery, King Abdulaziz University Hospital, P.O.BOX: 80215, Jeddah, 21589, Saudi Arabia.
  • Bahaidarah SA; Pediatric Cardiology Division, Department of Pediatrics, King Abdulaziz University Hospital, P.O.BOX: 80215, Jeddah, 21589, Saudi Arabia.
  • Al-Hassnan ZN; Center of Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Abdelmohsen GA; Pediatric Cardiology Division, Department of Pediatrics, King Abdulaziz University Hospital, P.O.BOX: 80215, Jeddah, 21589, Saudi Arabia.
J Saudi Heart Assoc ; 35(2): 144-147, 2023.
Article em En | MEDLINE | ID: mdl-37325369
ABSTRACT
Primary carnitine deficiency (PCD) is an autosomal recessive disorder characterized by decreased carnitine levels essential for Beta oxidation in various organs, including the heart. Early diagnosis and treatment of PCD can revert cardiomyopathy. A 13-year-old girl presented with heart failure due to dilated cardiomyopathy and severe cardiac dysfunction; following L carnitine treatment, the patient's clinical conditions improved, and cardiac functions returned to normal within weeks. Investigations revealed PCD; regular L carnitine has been provided, all cardiac medications are discontinued, and the patient is doing well. We believe PCD should be ruled out in every patient with cardiomyopathy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article